Cargando…

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of new blindness in the western world and is becoming more of a socio-medical problem as the proportion of the aged population increases. There are multiple efforts underway to better understand this disease process. AMD involves the abnorm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herzlich, Alexandra A., Tuo, Jingsheng, Chan, Chi-Chao
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234091/ https://www.ncbi.nlm.nih.gov/pubmed/18288287 http://dx.doi.org/10.1155/2008/389507

Ejemplares similares

Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics
por: Liu, Melissa M, et al.
Publicado: (2012)

Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions
por: Popp, Nicholas, et al.
Publicado: (2013)

Evidence for Enhanced Tissue Factor Expression in Age-related Macular Degeneration
por: Cho, Youngeun, et al.
Publicado: (2010)

Wnt signaling in age-related macular degeneration: human macular tissue and mouse model
por: Tuo, Jingsheng, et al.
Publicado: (2015)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model
por: Ardeljan, Christopher P., et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
por: Dharancy, Sébastien, et al.
Publicado: (2009)

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
por: Dubuquoy, Laurent, et al.
Publicado: (2009)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
por: Nishida, K., et al.
Publicado: (2008)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Age-related macular degeneration and the aging eye
por: Ehrlich, Rita, et al.
Publicado: (2008)

Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
por: Wang, Lin, et al.
Publicado: (2021)

Interleukin-17 Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting as a Cytokine Blocker: Implications for Age-Related Macular Degeneration
por: Ardeljan, Daniel, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer
por: Wagner, Nicole, et al.
Publicado: (2022)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
por: Psilopatis, Iason, et al.
Publicado: (2023)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
por: Sheng, Weibei, et al.
Publicado: (2023)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2014)

Age-Related Macular Degeneration and the Aging Brain
por: Whitson, Heather, et al.
Publicado: (2021)

Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
por: Kersten, Sander
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

Peroxisome Proliferator-Activated Receptors in Lung Cancer
por: Keshamouni, Venkateshwar G., et al.
Publicado: (2007)

Peroxisome Proliferator-Activated Receptors and Shock State
por: Esposito, Emanuela, et al.
Publicado: (2006)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
por: Fruchart, Jean-Charles
Publicado: (2013)

An update on the genetics of age-related macular degeneration
por: Scholl, Hendrik P.N., et al.
Publicado: (2007)

Age-related macular degeneration: current treatments
por: Hubschman, Jean Pierre, et al.
Publicado: (2009)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Aflibercept for the Treatment of Age-Related Macular Degeneration
por: Trichonas, George, et al.
Publicado: (2013)

Angiofluorographic aspects in age-related macular degeneration
por: Tomi, A, et al.
Publicado: (2014)

Fundus Autofluorescence in Age-related Macular Degeneration
por: Ly, Angelica, et al.
Publicado: (2017)

Vitamin D and Age-Related Macular Degeneration
por: Garcia Layana, Alfredo, et al.
Publicado: (2017)

The Role of Inflammation in Age-Related Macular Degeneration
por: Tan, Wei, et al.
Publicado: (2020)

Zinc and Autophagy in Age-Related Macular Degeneration
por: Blasiak, Janusz, et al.
Publicado: (2020)

Medication Trends for Age-Related Macular Degeneration
por: Cho, Yeon-Kyoung, et al.
Publicado: (2021)

The complement system in age-related macular degeneration
por: Armento, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gpomadfnftsqa3smjfc5c0meup